Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma.

MLA

Yijia, Zheng, et al. “Identification of Intratumoral Microbiome-Driven Immune Modulation and Therapeutic Implications in Diffuse Large B-Cell Lymphoma.” Cancer Immunology, Immunotherapy, vol. 74, no. 4, Mar. 2025, pp. 1–21. EBSCOhost, https://doi.org/10.1007/s00262-025-03972-x.

APA

Yijia, Z., Li, X., Ma, L., Wang, S., Du, H., Wu, Y., Yu, J., Xiang, Y., Xiong, D., Shan, H., Wang, Y., Wang, Z., Hao, J., & Wang, J. (2025). Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma. Cancer Immunology, Immunotherapy, 74(4), 1–21. https://doi.org/10.1007/s00262-025-03972-x

Chicago

Yijia, Zheng, Xiaoyu Li, Lina Ma, Siying Wang, Hong Du, Yun Wu, Jing Yu, et al. 2025. “Identification of Intratumoral Microbiome-Driven Immune Modulation and Therapeutic Implications in Diffuse Large B-Cell Lymphoma.” Cancer Immunology, Immunotherapy 74 (4): 1–21. doi:10.1007/s00262-025-03972-x.